Hyperimmune Serum Market

Hyperimmune Serum Market contains market size and forecasts of Hyperimmune Serum in global, including the following market information:

• Global Hyperimmune Serum Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Hyperimmune Serum Market Sales, 2017-2022, 2023-2028, (Kiloton)
• Global top five Hyperimmune Serum companies in 2021 (%)

The global Hyperimmune Serum market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hepatitis B Immunoglobulins Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hyperimmune Serum include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hyperimmune Serum manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hyperimmune Serum Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Hyperimmune Serum Market Segment Percentages, by Type, 2021 (%)

• Hepatitis B Immunoglobulins
• Rabies Immunoglobulins
• Tetanus Immunoglobulins
• Rho(D) Immunoglobulins
• Other

Global Hyperimmune Serum Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Hyperimmune Serum Market Segment Percentages, by Application, 2021 (%)

• Government Institutions
• Private Sector
• Other

Global Hyperimmune Serum Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Hyperimmune Serum Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Hyperimmune Serum revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Hyperimmune Serum revenues share in global market, 2021 (%)
• Key companies Hyperimmune Serum sales in global market, 2017-2022 (Estimated), (Kiloton)
• Key companies Hyperimmune Serum sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• CSL Behring
• Grifols
• Biotest
• Kedrion
• CBPO
• Emergent (Cangene)
• Kamada
• CNBG
• Hualan Bio
• Shanghai RAAS
• Sichuan Yuanda Shuyang
• ADMA Biologics